Justification for a Fixed Dose of Eflapegrastim, a LongâActing GâCSF, in Patients Receiving DocetaxelâCyclophosphamide Chemotherapy
Barrett, John A., Greene, Douglas, Lakshmikanthan, Sribalaji, Kolli, Prasad, Chawla, Shanta, Lebel, FrancoisJournal:
The Journal of Clinical Pharmacology
DOI:
10.1002/jcph.1723
Date:
August, 2020
File:
PDF, 550 KB
2020